Odyssey Therapeutics, Inc. (ODTX)
25.17
-1.22
(-4.62%)
USD |
NASDAQ |
Aug 24, 16:00
25.17
0.00 (0.00%)
After-Hours: 19:19
Odyssey Therapeutics Total Assets (Quarterly) : 483.85M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 483.85M |
| March 31, 2026 | 229.07M |
| June 30, 2025 |
| Date | Value |
|---|---|
| March 31, 2025 | |
| December 31, 2024 | 205.94M |
| December 31, 2023 | 295.85M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Anika Therapeutics, Inc. | 183.47M |
| Savara, Inc. | 192.14M |
| Vericel Corp. | 502.87M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 62.63M |
| Shareholders Equity (Quarterly) | 421.22M |
| Debt to Equity Ratio | 0.0589 |
| Current Ratio | 11.36 |
| Net Debt Paydown Yield | 0.21% |